• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. The prevalence of Osteoporosis and Fracture Risk in Chronic Hepatitis B patients with early stage li

The prevalence of Osteoporosis and Fracture Risk in Chronic Hepatitis B patients with early stage li

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：wangjj167
【摘 要】
：
Background:In hepatitis B virus(HBV) infection,osteopenia has been described,but the alterations in bone metabolism,bone mineral density(BMD) and fracture risk observed in chronic HBV infected patient
【作 者】
：
Ying Cao Renwen Zhang Chihong Wu Yu Zhang Fang Li Xiaxia Zhang Minran Li Xiaoyuan Xu 
【机 构】
：
Peking University First Hospital
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:In hepatitis B virus(HBV) infection,osteopenia has been described,but the alterations in bone metabolism,bone mineral density(BMD) and fracture risk observed in chronic HBV infected patients are incompletely understood.
其他文献
COMPARATIVE STUDY OF TELBIVUDINE AND PEGYLATED INTERFERON α-2a OPTIMIZATION THERAPY FOR E ANTIGEN-PO
Background:Aim To observe and compare the efficacy of telbivudine and pegalated interferon α-2a optimized therapy for E antigen-positive chronic hepatitis B patients.
会议
Low prevalence of Hepatitis B virus infection in patients with autoimmune diseases in a Chinese pati
Background:Hepatitis B is a very common communicable disease in China but the prevalence of hepatitis B virus(HBV) infection in patients with autoimmune diseases is unknown.We retrospectively investig
会议
The effect of complemental Ganshuang granule for improving liver fibrosis markers in patients with c
Background:To observe the ability of Ganshuang granules to improve markers of liver fibrosis when provided as supplemental therapy in patients with chronic hepatitis B(CHB) who achieved complete virol
会议
A NOVEL IMMUNOTHERAPY APPROACH WITH MULTIPLE TUMOR ANTIGENS ACTIVATED AUTOLOGOUS T CELLS IN HBV RELA
Background:Hepatocellular carcinoma(HCC) in China frequently occurs in the patients with chronic hepatitis B virus(HBV) infection.Here we present a novel approach(Smart T) of adoptive immunotherapy to
会议
ESTABLISHMENT AND VALIDATION OF ALPH-Q SCORE TO PREDICT MORTALITY RISK IN PATIENTS WITH ACUTE-ON-CHR
Background:There are no strong and powerful models in predicting the outcome of acute-on-chronic hepatitis B liver failure(ACHBLF).Here,we aimed to establish and validate a new prognostic score,named
会议
The diagnostic evaluation to the noninvasive diagnostic of HBV-related cirrhosis with the lantent cl
Background:There are many ways of diagnosis for the HBV-relative cirrhosis,especially,the noninvasive diagnosis,which had been widely used.Before these tests are applied to the clinic,which should be
会议
Identification of peptides for an individualised therapeutic vaccine for chronic hepatitis B
Background:A therapeutic vaccine for chronic hepatitis B that is individualised to contain only peptides specific to each patients HLA class I genotype should have the lowest risk of side effects,and
会议
The lower replication capacity of hepatitis B virus genotype C2 than B2 isolates correlates with low
Background:Infection by hepatitis B virus(HBV)genotype C leads to delayed HBeAg seroconversion than genotype B infection,which increases the risk for liver cancer.Our previous transfection experiments
会议
The clinical value of noninvasive assessment with acoustic radiation force impulse imaging for liver
Background:To investigate clinical application value of acoustic radiation force impulse(ARFI)in the assessment of liver fibrosis.
会议
Serum cytokine/chemokine profiles during the natural course of chronic hepatitis B
Background:Cytokines and chemokines have been demonstrated to play a vital role in directing and regulating immune responses to viral infections.Persistent hepatitis B virus(HBV) infection is characte
会议